000836860 001__ 836860
000836860 005__ 20210129231118.0
000836860 0247_ $$2doi$$a10.1055/s-0043-108194
000836860 0247_ $$2ISSN$$a0302-4350
000836860 0247_ $$2ISSN$$a1438-9428
000836860 0247_ $$2WOS$$aWOS:000407300300003
000836860 037__ $$aFZJ-2017-05896
000836860 082__ $$a610
000836860 1001_ $$0P:(DE-HGF)0$$aGolla, Heidrun$$b0
000836860 245__ $$aPalliativmedizinische Versorgung neurologischer Patienten. Palliative care for neurological patients.
000836860 260__ $$aStuttgart$$bThieme$$c2017
000836860 3367_ $$2DRIVER$$aarticle
000836860 3367_ $$2DataCite$$aOutput Types/Journal article
000836860 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1502694256_6482
000836860 3367_ $$2BibTeX$$aARTICLE
000836860 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000836860 3367_ $$00$$2EndNote$$aJournal Article
000836860 520__ $$aAlthough patients with incurable neurological diseases suffer from a variety of distressing symptoms and may die from their neurological condition and associated complications, palliative and hospice care for these patients to date remains rare. First estimates envisage that on average 10 % of all patients suffering from a neurological disease need palliative and hospice care. However, within German neurology departments, only few physicians (on average 1.3 /department) and nurses (on average 2.2./department) are specialized in palliative and hospice care and only about 3 % of patients cared for in palliative or hospice care structures suffer from neurological diseases (in contrast to patients suffering from oncological diseases, approximately 80 %). Responsible for this rather low number is a just gradual increase in the awareness of palliative and hospice care needs for neurological patients and a currently predominant supply of oncological patients in palliative and hospice care structures which are primarily aimed at these patients. In line with this is that the special aspects of neurological patients are currently not adequately addressed in the palliative training curricula of health care professionals. Rather, patients with advanced neurological conditions are medically cared for by general practitioners and by the existing inpatient and outpatient neurological structures, which may also offer sub-specialty services. Consequently, adequate care for severely affected neurological patients becomes difficult as soon as these patients are hardly able to visit these structures since home-based specialist treatment is currently only limitedly carried out and financed. Novel yet to date rare approaches, mostly of international origin, suggest that these patients may benefit from specialized home based services, combining neurological and palliative care expertise. At present, data that characterize the situation of neuro-palliative care in Germany remain scarce. In addition to the already known supply gaps (e. g. low rate of neurologists trained in palliative medicine as well as of nurses working in neurology trained in palliative care, lacking consideration of the specific (care) needs of neurological patients in general and specialized palliative and hospice care structures, hardly available home-based outpatient specialists) research is a prerequisite to identify current gaps in palliative care of neurological patients in more detail and how these might be overcome in the future.
000836860 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000836860 588__ $$aDataset connected to CrossRef
000836860 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b1$$ufzj
000836860 7001_ $$0P:(DE-HGF)0$$aRolke, Roman$$b2
000836860 7001_ $$0P:(DE-HGF)0$$aLorenzl, Stefan$$b3
000836860 7001_ $$0P:(DE-HGF)0$$aEbke, Markus$$b4
000836860 7001_ $$0P:(DE-HGF)0$$aMontag, Thomas$$b5
000836860 7001_ $$0P:(DE-HGF)0$$aGold, Ralf$$b6
000836860 7001_ $$0P:(DE-HGF)0$$aNelles, Gereon$$b7
000836860 7001_ $$0P:(DE-HGF)0$$aEggers, Carsten$$b8
000836860 7001_ $$0P:(DE-HGF)0$$aVoltz, Raymond$$b9
000836860 773__ $$0PERI:(DE-600)2056721-2$$a10.1055/s-0043-108194$$gVol. 44, no. 06, p. 388 - 399$$n06$$p388 - 399$$tAktuelle Neurologie$$v44$$x1438-9428$$y2017
000836860 909CO $$ooai:juser.fz-juelich.de:836860$$pVDB
000836860 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b1$$kFZJ
000836860 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000836860 9141_ $$y2017
000836860 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000836860 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000836860 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000836860 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index
000836860 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000836860 920__ $$lyes
000836860 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000836860 980__ $$ajournal
000836860 980__ $$aVDB
000836860 980__ $$aI:(DE-Juel1)INM-3-20090406
000836860 980__ $$aUNRESTRICTED